LENZ
NASDAQ · Pharmaceuticals
Lenz Therapeutics Inc
$9.15
-0.13 (-1.40%)
Open$9.34
Previous Close$9.28
Day High$9.48
Day Low$9.13
52W High$50.40
52W Low$8.25
Volume—
Avg Volume818.2K
Market Cap304.76M
P/E Ratio—
EPS$-2.80
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+52.8% upside
Current
$9.15
$9.15
Target
$13.98
$13.98
$9.74
$13.98 avg
$16.17
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 22.07M | 61.59M | 55.54M |
| Net Income | -94,936,714 | 19.38M | 14.59M |
| Profit Margin | -430.3% | 31.5% | 26.3% |
| EBITDA | -105,302,046 | 32.48M | 26.94M |
| Free Cash Flow | — | 24.80M | 19.95M |
| Rev Growth | — | +17.7% | +18.8% |
| Debt/Equity | — | 0.99 | 1.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |